Evolent Health Stock

Evolent Health EBIT

The EBIT of Evolent Health (EVH) as of Aug 6, 2026 is -477.17 M USD. In the previous year, EBIT was -38.31 M USD — a change of 1,145.41% (lower).

EBIT

-477.17 MUSD

YoY

1,145.41%

Last updated:

In 2026, Evolent Health's EBIT was -477.17 M USD, a 1,145.41% increase from the -38.31 M USD EBIT recorded in the previous year.

The Evolent Health EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT (M USD)
Date
EBIT (M USD)
Jan 1, 2023
-71.21 base
Jan 1, 2024
-38.31 base
Jan 1, 2025
-477.17 base
Jan 1, 2026 (e)
-192.25 base
Jan 1, 2027 (e)
-226.04 base
Jan 1, 2028 (e)
-252.48 base
Jan 1, 2029 (e)
-285.45 base
Jan 1, 2030 (e)
-314.58 base
YEAREBIT (M USD)
2030 est -314.58
2029 est -285.45
2028 est -252.48
2027 est -226.04
2026 est -192.25
2025 -477.17
2024 -38.31
2023 -71.21
2022 3.64
2021 -42.41
2020 -302.22
2019 -319.44
2018 -52.11
2017 -74.42
2016 -237.42
2015 -42.97
2014 -25.25
2013 -21.16
2012 -19.62
Access this data via the Eulerpool API

Evolent Health Revenue

Evolent Health Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2023
1.96 B USD
-71.21 M USD
-113.04 M USD
Jan 1, 2024
2.55 B USD
-38.31 M USD
-61.62 M USD
Jan 1, 2025
1.88 B USD
-477.17 M USD
-534.51 M USD
Jan 1, 2026 (e)
2.50 B USD
-192.25 M USD
20.17 M USD
Jan 1, 2027 (e)
2.94 B USD
-226.04 M USD
39.33 M USD
Jan 1, 2028 (e)
3.29 B USD
-252.48 M USD
51.20 M USD
Jan 1, 2029 (e)
3.72 B USD
-285.45 M USD
78.12 M USD
Jan 1, 2030 (e)
4.10 B USD
-314.58 M USD
92.63 M USD

Evolent Health Margins

Evolent Health stock margins

The Evolent Health margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Evolent Health. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Evolent Health.
  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2023
23.45 %
-3.63 %
-5.76 %
Jan 1, 2024
14.38 %
-1.50 %
-2.41 %
Jan 1, 2025
15.14 %
-25.43 %
-28.49 %
Jan 1, 2026 (e)
15.14 %
-7.68 %
0.81 %
Jan 1, 2027 (e)
15.14 %
-7.68 %
1.34 %
Jan 1, 2028 (e)
15.14 %
-7.68 %
1.56 %
Jan 1, 2029 (e)
15.14 %
-7.68 %
2.10 %
Jan 1, 2030 (e)
15.14 %
-7.68 %
2.26 %

Evolent Health Stock analysis

What does Evolent Health do? Evolent Health Inc was founded in 2011 and is a healthcare services company based in Arlington, VA USA. The company was founded by a group of CEOs and executives to revolutionize the healthcare system and reduce healthcare costs in the US. Evolent, a wordplay on "evolution" and "diligent," is committed to improving healthcare services through innovative ideas and technologies. Over the years, Evolent Health's business model has evolved and expanded to meet the needs of a wide range of healthcare organizations and their patients. The company works with healthcare organizations such as hospitals, medical centers, health plans, and physicians to provide effective and affordable healthcare solutions. Evolent Health offers various services tailored to the needs of different healthcare organizations. One of their core competencies is the development and implementation of population health management programs. These programs aim to improve patient health while reducing costs. The company also offers technology platforms that healthcare organizations can use to manage data, improve treatment outcomes, and facilitate communication between doctors and patients. Another important aspect of Evolent Health is the care of Medicare and Medicaid patients. The company works with health plans to provide better healthcare services to these underserved populations. Evolent Health also offers specialized services, such as the treatment of patients with chronic conditions like diabetes or cardiovascular diseases. In recent years, Evolent Health has also expanded its portfolio through acquisitions and partnerships. In 2018, two acquisitions were completed, namely Valence Health and New Century Health. These acquisitions have strengthened Evolent Health's position in the field of population health management programs and specialized services for cancer patients. Another innovative product of Evolent Health is the Virtual Health Center. This program offers virtual consultations and treatments for patients who cannot make in-person visits to doctors due to distance or busy lifestyles. The program utilizes state-of-the-art telemedicine technology to provide patients with high-quality medical care while allowing them to stay comfortably at home. Evolent Health has an impressive track record in improving patient outcomes and reducing healthcare costs. In 2020, the company received the highest rating in the "Population Health Management" category of the Healthcare Informatics 100 Rankings. The company serves nearly 3 million patients in the US and operates in over 30 states. Overall, the company has the potential to change the healthcare system in the US and beyond through its vision, innovation, and commitment to high-quality healthcare services. Evolent's focus on improving healthcare delivery and reducing costs has the potential to be a role model for the entire industry. Evolent Health is one of the most popular companies on Eulerpool.

EBIT Details

Analyzing Evolent Health's EBIT

Evolent Health's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of Evolent Health's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

Evolent Health's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in Evolent Health’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about Evolent Health stock

EBIT of Evolent Health is -477.17 M USD in 2026.

EBIT of Evolent Health changed from -38.31 M USD to -477.17 M USD, representing a 1,145.41% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Evolent Health since 2006 – with annual values, charts, and detailed analysis.

"Earnings before interest and taxes", abbreviated as EBIT, is also referred to as the operating result of a company. It is a key figure that allows the profit to be assessed over a specific period of time, usually a fiscal year. Taxes and interest are not deducted from EBIT, making it suitable for international comparisons of different companies.

Net income
+ Tax expense
+ Interest expense and other financial expenses
- Interest income and other financial income
= EBIT (operating profit)

EBIT's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBIT's Evolent Health historically and in real time.

The sales revenue is important for evaluating a stock.

EBIT is an acronym for "Earnings Before Interest and Tax" and represents a company's gross profit before taxes and interest are deducted. The EBIT amount is often used as a metric to evaluate a company.

History

The EBIT was originally introduced in the 1940s when the US Internal Revenue Service (IRS) passed a new tax law. This law required companies to calculate their profit before deducting taxes and interest on loans (or "interest and taxes"). Since then, the EBIT has been used as one of the key financial indicators in evaluating a company.

Usage

The EBIT can be used to assess a company by comparing its financial results to a benchmark or a comparative value. The EBIT is also used to determine how much the company's shareholders will receive from its operating income.

Calculation

EBIT is calculated by deducting taxes and interest on loans from the company's net profit. This amount can be calculated in various ways, but the most common method is as follows:

EBIT = Net profit + interest and taxes

Example: Eulerpool: Your source for quantitative stock data At Eulerpool, we are dedicated to providing you with comprehensive and accurate stock information. Our website offers a wide range of tools and features, including charts, stock lists, and more. Whether you are an experienced investor or just starting out, our platform is designed to meet your needs. With our in-depth analytics and algorithms, you can make informed decisions and stay ahead of the market. Explore our extensive collection of stocks, track their performance, and access real-time data. With Eulerpool, you can easily navigate the world of finance and monitor the stocks that matter to you. Join our community today and gain valuable insights into the world of stocks and investments. Sign up for free and discover the power of Eulerpool. Stay informed. Stay ahead. Eulerpool - your trusted partner in stock data.
Net profit of XYZ Co. = $1,000,000
Interest and taxes = $ 500,000
EBIT of XYZ Co. = $1,500,000

Application

The EBIT value is often used to determine and evaluate the financial stability of a company. The EBIT value can also be used to determine how much money a company can spend on investments or dividends.

Use of EBIT in stock investment

Investors use EBIT to determine if a stock is over- or undervalued. If a company has a high EBIT value, it may indicate that its stock is overvalued, as the profit it generates could be lower than what it would generate with a different stock.

Advantages of EBIT

EBIT is a helpful measure for determining the financial stability of a company. There are several advantages associated with using EBIT, such as:
- EBIT eliminates the impact of financing on the company's earnings.
- It is a useful measure for determining the profits that a company can distribute to its shareholders.
- It can be used to determine whether a stock is overvalued or undervalued.

Disadvantages of EBIT

There are also some disadvantages to using EBIT, such as:
- EBIT cannot be used as the sole measure to evaluate a company as it does not reflect the overall profit of the company.
- EBIT can be influenced by unforeseen events such as a tax increase.
- EBIT is not always a reliable indicator of a company's future profit development.

Conclusion

The EBIT is an important measure used to evaluate a company. It can be used to determine how much money a company can generate from its operational results and whether a stock is overvalued or undervalued. However, the EBIT also has some disadvantages as it does not reflect the overall profitability of a company and can be influenced by unforeseen events. Therefore, it is important to consider the EBIT in conjunction with other financial indicators to obtain a complete picture of the company.

Access this data via the Eulerpool API

Income Statement — Evolent Health

All Key Metrics — Evolent Health